Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2020-02-26 21:41:09 UTC |
---|
HMDB ID | HMDB0015192 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Norfloxacin |
---|
Description | Norfloxacin is only found in individuals that have used or taken this drug. It is a synthetic fluoroquinolone (fluoroquinolones) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA gyrase. [PubChem]The bactericidal action of Norfloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination. Norfloxacin is a broad-spectrum antibiotic that is active against both gram-positive and gram-negative bacterias. The fluorine atom at the 6 position increases potency against gram-negative organisms, and the piperazine moiety at the 7 position is responsible for anti-pseudomonal activity |
---|
Structure | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1 InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23) |
---|
Synonyms | Value | Source |
---|
1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid | ChEBI | 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure | ChEBI | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid | ChEBI | NFLX | ChEBI | Norfloxacine | ChEBI | Norfloxacino | ChEBI | Norfloxacinum | ChEBI | Noroxin | Kegg | 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate | Generator | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate | Generator | Merck brand OF norfloxacin | HMDB | Norfloxacin merck brand | HMDB |
|
---|
Chemical Formula | C16H18FN3O3 |
---|
Average Molecular Weight | 319.3308 |
---|
Monoisotopic Molecular Weight | 319.133219662 |
---|
IUPAC Name | 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid |
---|
Traditional Name | norfloxacin |
---|
CAS Registry Number | 70458-96-7 |
---|
SMILES | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1 |
---|
InChI Identifier | InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23) |
---|
InChI Key | OGJPXUAPXNRGGI-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-alpha-amino acids |
---|
Alternative Parents | |
---|
Substituents | - L-alpha-amino acid
- Dihydropyridine
- Hydroxypyridine
- Hydropyridine
- Pyridine
- Heteroaromatic compound
- Vinylogous amide
- Amino acid
- Cyclic ketone
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Azacycle
- Organoheterocyclic compound
- Amine
- Hydrocarbon derivative
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Primary aliphatic amine
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 227 - 228 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1.01 g/L | Not Available | LogP | 2.1 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Norfloxacin,1TMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C)C(=O)C2=CC(F)=C(N3CCNCC3)C=C21 | 2886.8 | Semi standard non polar | 33892256 | Norfloxacin,1TMS,isomer #2 | CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C)CC3)C=C21 | 3006.8 | Semi standard non polar | 33892256 | Norfloxacin,2TMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C)CC3)C=C21 | 2933.4 | Semi standard non polar | 33892256 | Norfloxacin,2TMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C)CC3)C=C21 | 2902.9 | Standard non polar | 33892256 | Norfloxacin,2TMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C)CC3)C=C21 | 3436.3 | Standard polar | 33892256 | Norfloxacin,1TBDMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C(C)(C)C)C(=O)C2=CC(F)=C(N3CCNCC3)C=C21 | 3100.1 | Semi standard non polar | 33892256 | Norfloxacin,1TBDMS,isomer #2 | CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C(C)(C)C)CC3)C=C21 | 3250.6 | Semi standard non polar | 33892256 | Norfloxacin,2TBDMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C(C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C(C)(C)C)CC3)C=C21 | 3357.0 | Semi standard non polar | 33892256 | Norfloxacin,2TBDMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C(C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C(C)(C)C)CC3)C=C21 | 3310.6 | Standard non polar | 33892256 | Norfloxacin,2TBDMS,isomer #1 | CCN1C=C(C(=O)O[Si](C)(C)C(C)(C)C)C(=O)C2=CC(F)=C(N3CCN([Si](C)(C)C(C)(C)C)CC3)C=C21 | 3608.7 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Norfloxacin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ufu-1092000000-bf3fd3d7faa91b8515de | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norfloxacin GC-MS (1 TMS) - 70eV, Positive | splash10-00b9-2029000000-1c3a70fd1922acc3da89 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norfloxacin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norfloxacin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-qTof , Positive-QTOF | splash10-03di-0910000000-71f0a353a8e37a26b402 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-QTOF , positive-QTOF | splash10-00di-0019000000-209bfb114ccbb6d9e304 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-QTOF , positive-QTOF | splash10-00di-0069000000-4d54becdaa4caedbe3b2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-QTOF , positive-QTOF | splash10-001i-0391000000-a84cfa736c2dcec4d545 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-0ufr-0069000000-246d2ae5a6ec6a55d6b1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-00di-0009000000-f809266e62551b06d730 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-0fmi-0039000000-b7128cd18b98a04daf9e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-0udi-0069000000-d5c4d2c4b68d5f6d03a2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-0ue9-0095000000-901dbfc8f7d02a135c4d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-001i-0491000000-be9683c47fbf7a3cb0ba | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-001i-0970000000-90dc103f49990c57d26f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-00di-0009000000-13d5054c01078e14d8f0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-0fmi-0039000000-74150f6e5c4d2dcba6ab | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-0udi-0059000000-dd2ee816e5228385835d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-0f89-0195000000-596094ef32a4ddd39544 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-001i-0491000000-20c74694b378fdb752b2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-001i-0970000000-06c84236dac00c44e42e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin LC-ESI-ITFT , positive-QTOF | splash10-0ufr-0069000000-5c4650a9bab59ded6701 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norfloxacin , positive-QTOF | splash10-03di-0910000000-71f0a353a8e37a26b402 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norfloxacin 10V, Positive-QTOF | splash10-00di-0029000000-71b732750ca6ae35eeaf | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norfloxacin 20V, Positive-QTOF | splash10-0fmi-1095000000-f6c15b3b64948217c713 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norfloxacin 40V, Positive-QTOF | splash10-0a4l-3190000000-5eb0c3a916bc08140fc5 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norfloxacin 10V, Negative-QTOF | splash10-00xr-0095000000-ecc84ee43ade0cae1058 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norfloxacin 20V, Negative-QTOF | splash10-00di-1090000000-39e213194d7a6b6854f0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norfloxacin 40V, Negative-QTOF | splash10-000f-5290000000-7214f42f26930bf54144 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|